These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16023993)

  • 21. The cGMP-binding, cGMP-specific phosphodiesterase (PDE5): intestinal cell expression, regulation and role in fluid secretion.
    Sopory S; Kaur T; Visweswariah SS
    Cell Signal; 2004 Jun; 16(6):681-92. PubMed ID: 15093609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
    Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A
    Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New achievement and novel therapeutic applications of PDE5 inhibithors in older males.
    Frajese GV; Pozzi F
    J Endocrinol Invest; 2005; 28(3 Suppl):45-50. PubMed ID: 16042360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors].
    Ghofrani HA; Grimminger F
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S311-4. PubMed ID: 17139594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease.
    Ravipati G; McClung JA; Aronow WS; Peterson SJ; Frishman WH
    Cardiol Rev; 2007; 15(2):76-86. PubMed ID: 17303994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.
    Kloner RA
    Am J Cardiol; 2005 Dec; 96(12B):42M-46M. PubMed ID: 16387566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms.
    Tinel H; Stelte-Ludwig B; Hütter J; Sandner P
    BJU Int; 2006 Dec; 98(6):1259-63. PubMed ID: 16956354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylation of phosphodiesterase-5 is promoted by a conformational change induced by sildenafil, vardenafil, or tadalafil.
    Bessay EP; Zoraghi R; Blount MA; Grimes KA; Beasley A; Francis SH; Corbin JD
    Front Biosci; 2007 Jan; 12():1899-910. PubMed ID: 17127429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities.
    Corbin JD; Turko IV; Beasley A; Francis SH
    Eur J Biochem; 2000 May; 267(9):2760-7. PubMed ID: 10785399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of serotonin transport by the cyclic GMP phosphodiesterase-5 inhibitor sildenafil.
    Zhu CB; Hewlett WA; Francis SH; Corbin JD; Blakely RD
    Eur J Pharmacol; 2004 Nov; 504(1-2):1-6. PubMed ID: 15507214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells.
    Zhu B; Vemavarapu L; Thompson WJ; Strada SJ
    J Cell Biochem; 2005 Feb; 94(2):336-50. PubMed ID: 15526282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in mouse tissues and cell lines using an antibody against the enzyme amino-terminal domain.
    Giordano D; De Stefano ME; Citro G; Modica A; Giorgi M
    Biochim Biophys Acta; 2001 May; 1539(1-2):16-27. PubMed ID: 11389965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats.
    Ferreira-Melo SE; Yugar-Toledo JC; Coelho OR; De Luca IM; Tanus-Santos JE; Hyslop S; Irigoyen MC; Moreno H
    Eur J Pharmacol; 2006 Aug; 542(1-3):141-7. PubMed ID: 16806160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of Phosphodiesterase 5 inhibitor relief of prostatitis symptoms.
    Grimsley SJ; Khan MH; Jones GE
    Med Hypotheses; 2007; 69(1):25-6. PubMed ID: 17300876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allosteric sites of phosphodiesterase-5 (PDE5). A potential role in negative feedback regulation of cGMP signaling in corpus cavernosum.
    Gopal VK; Francis SH; Corbin JD
    Eur J Biochem; 2001 Jun; 268(11):3304-12. PubMed ID: 11389733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione analogues.
    Daugan A; Grondin P; Ruault C; Le Monnier de Gouville AC; Coste H; Linget JM; Kirilovsky J; Hyafil F; Labaudinière R
    J Med Chem; 2003 Oct; 46(21):4533-42. PubMed ID: 14521415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
    de Vente J; Markerink-van Ittersum M; Vles JS
    J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of PDE5-inhibitors in cardiopulmonary disorders: from basic evidence to clinical development.
    Guazzi M; Samaja M
    Curr Med Chem; 2007; 14(20):2181-91. PubMed ID: 17691956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development.
    Sanchez LS; de la Monte SM; Filippov G; Jones RC; Zapol WM; Bloch KD
    Pediatr Res; 1998 Feb; 43(2):163-8. PubMed ID: 9475279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
    Forfia PR; Lee M; Tunin RS; Mahmud M; Champion HC; Kass DA
    J Am Coll Cardiol; 2007 Mar; 49(10):1079-88. PubMed ID: 17349888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.